These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26185131)

  • 1. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity.
    Messmann JJ; Reisser T; Leithäuser F; Lutz MB; Debatin KM; Strauss G
    Blood; 2015 Aug; 126(9):1138-48. PubMed ID: 26185131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-Versus-Host Disease Prevention by
    Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
    Front Immunol; 2021; 12():754316. PubMed ID: 34721430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
    Highfill SL; Rodriguez PC; Zhou Q; Goetz CA; Koehn BH; Veenstra R; Taylor PA; Panoskaltsis-Mortari A; Serody JS; Munn DH; Tolar J; Ochoa AC; Blazar BR
    Blood; 2010 Dec; 116(25):5738-47. PubMed ID: 20807889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.
    Koehn BH; Apostolova P; Haverkamp JM; Miller JS; McCullar V; Tolar J; Munn DH; Murphy WJ; Brickey WJ; Serody JS; Gabrilovich DI; Bronte V; Murray PJ; Ting JP; Zeiser R; Blazar BR
    Blood; 2015 Sep; 126(13):1621-8. PubMed ID: 26265697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
    Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early myeloid-derived suppressor cells (HLA-DR
    Wang K; Lv M; Chang YJ; Zhao XY; Zhao XS; Zhang YY; Sun YQ; Wang ZD; Suo P; Zhou Y; Liu D; Zhai SZ; Hong Y; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    J Hematol Oncol; 2019 Mar; 12(1):31. PubMed ID: 30885244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.
    Wang D; Yu Y; Haarberg K; Fu J; Kaosaard K; Nagaraj S; Anasetti C; Gabrilovich D; Yu XZ
    Biol Blood Marrow Transplant; 2013 May; 19(5):692-702. PubMed ID: 23376089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.
    Pan L; Delmonte J; Jalonen CK; Ferrara JL
    Blood; 1995 Dec; 86(12):4422-9. PubMed ID: 8541530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.
    Scheurer J; Reisser T; Leithäuser F; Messmann JJ; Holzmann K; Debatin KM; Strauss G
    Clin Exp Immunol; 2020 Dec; 202(3):407-422. PubMed ID: 32681646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
    Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
    Front Immunol; 2019; 10():183. PubMed ID: 30863394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
    Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th2 polarization in target organs is involved in the alleviation of pathological damage mediated by transplanting granulocyte colony-stimulating factor-primed donor T cells.
    Zhou Y; Cao L; Guo H; Hong Y; Wang M; Wang K; Huang X; Chang Y
    Sci China Life Sci; 2021 Jul; 64(7):1087-1096. PubMed ID: 32880861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.
    Lim JY; Lee YK; Lee SE; Ju JM; Eom KS; Kim YJ; Chung NG; Jeong DC; Park G; Choi EY; Min CK
    Mucosal Immunol; 2016 May; 9(3):730-43. PubMed ID: 26442657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of granulocyte colony stimulating factor on myeloid-derived suppressor cells in the bone marrow and peripheral blood: a preliminary study].
    Ling YW; Liu QF; Liu C; Wu XL; Chen YK; Fan ZP; Xuan L; Zhang Y; Jiang QL; Zhao J; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1190-2. PubMed ID: 21764692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
    Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
    Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.
    Zhang J; Chen HM; Ma G; Zhou Z; Raulet D; Rivera AL; Chen SH; Pan PY
    Leukemia; 2019 Aug; 33(8):2078-2089. PubMed ID: 30737483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells.
    Hashimoto D; Asakura S; Miyake S; Yamamura T; Van Kaer L; Liu C; Tanimoto M; Teshima T
    J Immunol; 2005 Jan; 174(1):551-6. PubMed ID: 15611282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.